Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 1/20 | 0.42 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10744608 | 0.97 | GABRA1 (0.41) | GABRA1GABRB2MAPK1TDP1 | |
| SCHEMBL583614 | 0.90 | GABRA1 (0.41) | GABRA1GABRB2MAPK1TDP1 | |
| SCHEMBL11728511 | 0.83 | GABRA1 (0.38) | GABRA1GABRB2 | |
| SCHEMBL3837324 | 0.81 | MAPK1 (0.50) | GABRA1GABRB2MAPK1TDP1 | |
| SCHEMBL6156139 | 0.79 | GABRA1 (0.35) | GABRA1GABRB2 | |
| SCHEMBL10884153 | 0.75 | GABRA1 (0.36) | GABRA1GABRB2 | |
| SCHEMBL11351194 | 0.75 | GABRA1 (0.32) | GABRA1GABRB2 | |
| SCHEMBL8641955 | 0.75 | MAPK1 (0.50) | GABRA1GABRB2MAPK1TDP1 | |
| SCHEMBL11795584 | 0.74 | GABRA1 (0.32) | GABRA1GABRB2MAPK1TDP1 | |
| SCHEMBL8640423 | 0.74 | TDP1 (0.39) | GABRA1GABRB2MAPK1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 397 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4288443-A1 | MODIFIED GUAYULE RESIN PRODUCT AND RELATED PROCESSES | BRIDGESTONE CORPORATION (JP) | 2023-12-13 | — | — | EP | claimed |
| WO-2022170364-A1 | MODIFIED GUAYULE RESIN PRODUCT AND RELATED PROCESSES | BRIDGESTONE CORPORATION (JP) | 2022-08-11 | — | — | WO | claimed |
| US-7691959-B1 | Moisture curable silicone hot melt | HENKEL CORPORATION (US) | 2010-04-06 | — | — | US | claimed |
| US-20100061823-A1 | DRY-TO-THE-TOUCH ANAEROBICALLY CURABLE COMPOSITIONS AND PRODUCTS MADE THEREFROM | HENKEL CORPORATION (US) | 2010-03-11 | — | — | US | claimed |
| WO-2008153668-A2 | DRY-TO-THE-TOUCH ANAEROBICALLY CURABLE COMPOSITIONS AND PRODUCTS MADE THEREFROM | HENKEL CORPORATION (US) | 2008-12-18 | — | — | WO | claimed |
| EP-1971427-A1 | VISIBLE LIGHT CURING SYSTEMS, METHODS FOR REDUCING HEALTH RISKS TO INDIVIDUALS EXPOSED TO SYSTEMS DESIGNED TO CURE CURABLE COMPOSITIONS BY EXPOSURE TO RADIATION, METHODS FOR BONDING SUBSTRATES AND VISIBLE LIGHT CURING COMPOSITIONS | Henkel Corporation (US) | 2008-09-24 | — | — | EP | claimed |
| US-20080139687-A1 | Vinyl Ether/Acrylate Block Resins, Compositions and Methods of Making Same | HENKEL CORPORATION (US) | 2008-06-12 | — | — | US | claimed |
| WO-2007078851-A1 | VISIBLE LIGHT CURING SYSTEMS, METHODS FOR REDUCING HEALTH RISKS TO INDIVIDUALS EXPOSED TO SYSTEMS DESIGNED TO CURE CURABLE COMPOSITIONS BY EXPOSURE TO RADIATION, METHODS FOR BONDING SUBSTRATES AND VISIBLE LIGHT CURING COMPOSITIONS | HENKEL CORPORATION (US) | 2007-07-12 | — | — | WO | claimed |
| US-20070138411-A1 | Visible light curing systems, methods for reducing health risks to individuals exposed to systems designed to cure curable compositions by exposure to radiation, methods for bonding substrates and visible light curing compositions | HENKEL CORPORATION | 2007-06-21 | — | — | US | claimed |
| WO-2006083343-A1 | VINYL ETHER/ACRYLATE BLOCK RESINS, COMPOSITIONS AND METHODS OF MAKING SAME | HENKEL CORPORATION (US) | 2006-08-10 | — | — | WO | claimed |
| US-5359014-A | Low temperature curing | CYTEC TECHNOLOGY CORP. (US) | 1994-10-25 | — | — | US | claimed |
| US-5175201-A | VINYL-TERMINATED CARBAMYLMETHYLATED MELAMINES, VINYL-TERMINATED POLYURETHANE/POLYAMIDE POLYMERS AND COATING/ADHESIVE COMPOSITIONS CONTAINING SAME | AMERICAN CYANAMID COMPANY (US) | 1992-12-29 | — | — | US | claimed |
| EP-0010355-B1 | PHOTO-HARDENABLE COMPOSITION, METHOD OF BONDING MATERIALS THEREWITH AND LAMINATES OBTAINED | DELTAGLASS S.A. (CH) | 1983-06-22 | — | — | EP | claimed |
| US-4355077-A | Photocured lamina of unsaturated urethane/monomer adhesive blend with a transparent layer | DELTAGLASS S.A. (CH) | 1982-10-19 | — | — | US | claimed |
| US-4297185-A | Photosetting adhesive from unsaturated oligomer, photoinitiator, and betaine-forming mixture of unsaturated tert.amine and unsaturated acid | TECHINTER S.A. (CH) | 1981-10-27 | — | — | US | claimed |
| EP-0010355-A1 | Photo-hardenable composition, method of bonding materials therewith and laminates obtained | DELTAGLASS S.A. (CH) | 1980-04-30 | — | — | EP | claimed |
| US-20260009940-A1 | OPTICAL LAMINATE AND IMAGE DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2026-01-08 | — | — | US | disclosed |
| US-12461296-B2 | Optical laminate and image display device | FUJIFILM CORPORATION (JP) | 2025-11-04 | — | — | US | disclosed |
| US-4001180-A | METHYLENEBIS(METHYL ANTHRANILATE) AND AN ISOCYANATE-TERMINATED PREPOLYMER | DOYLE EARL N | 1977-01-04 | — | — | US | disclosed |
| US-3931678-A | Dental filling method and composition formed thereby | LOCTITE (IRELAND) LIMITED (EI) | 1976-01-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260009940-A1 | OPTICAL LAMINATE AND IMAGE DISPLAY DEVICE | CDH1, ITGA1, ITGAL | GABRA1 3595/4885GABRB2 4102/4885MAPK1 1563/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.